A recent study indicates that patients who stop using blockbuster weight-loss injections like Wegovy and Mounjaro can put back on shed pounds much more quickly than those who stop conventional lifestyle plans.
Published data in a prominent health publication demonstrates that while overweight individuals frequently drop a large proportion of their total mass while on the medication, the mass comes back at an estimated rate of 0.8 kg per month after stopping.
"Users purchasing such medications need to be informed of the danger of rapid rebound weight gain when the treatment ends," stated expert Dr. Susan Jebb.
This pace of regain implies a return to original mass within about a year and a half.
Analyzing Therapies
The study, which looked at 37 of studies involving thousands of patients, compared the outcomes of GLP-1 agonists with older methods.
Scientists point out that individuals who shed pounds through lifestyle changes alone usually experience a slower creep back—around 100 grams monthly—post-intervention.
Understanding the Fast Rebound
Nutrition scientists suggest the mechanism of the injections is key to understanding the accelerated rebound.
The injections imitate a body's own chemical called glucagon-like peptide-1, which helps regulate appetite.
"Sustained high doses of GLP-1 levels far above than the body's typical production may cause the system to produce less of its own natural GLP-1, and could diminish sensitivity to its effects," said Dr. Adam Collins, a nutrition expert.
"Stopping of this GLP-1 'fix' leads to hunger is unsuppressed, making excessive eating far more likely."
A Lifelong Disease?
Medical guidelines advise the injections for people with weight-linked medical conditions, alongside prescribed lifestyle changes.
A number of clinicians argue that, given the likelihood of weight regain, the therapy is often life-long.
This view is reinforced by pharmaceutical companies, who say that the findings "emphasize the long-term nature of obesity," similar to managing conditions like diabetes.
User Experiences
People who have stopped the medication explain a powerful return of appetite.
"It felt as if a trigger that goes on and you become extremely hungry," recalled one woman.
The struggle is exacerbated if users have not developed permanent lifestyle or habit modifications during treatment.
Growing Adoption
Figures show that a significant number of people in the UK have used weight-loss jabs in the last 12 months, with demand continuing to grow.
- Use is greater among females than males.
- The 40s and 50s age group shows the highest level of interest.
- Many access the medications through private prescriptions rather than public health services.
Finally, experts caution that while GLP-1 drugs are effective tools for weight loss, they are not a permanent cure and lasting health benefits hinges on integrated lifestyle support.
